217 related articles for article (PubMed ID: 18320519)
1. Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma.
Chalam KV; Gupta SK; Grover S; Brar VS; Agarwal S
Eur J Ophthalmol; 2008; 18(2):255-62. PubMed ID: 18320519
[TBL] [Abstract][Full Text] [Related]
2. Intracameral bevacizumab for iris rubeosis.
Grisanti S; Biester S; Peters S; Tatar O; Ziemssen F; Bartz-Schmidt KU;
Am J Ophthalmol; 2006 Jul; 142(1):158-60. PubMed ID: 16815268
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
Avery RL; Pearlman J; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ; Wendel R; Patel A
Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951
[TBL] [Abstract][Full Text] [Related]
5. In vivo corneal endothelial safety of intracameral bevacizumab and effect in neovascular glaucoma combined with Ahmed valve implantation.
Shin JP; Lee JW; Sohn BJ; Kim HK; Kim SY
J Glaucoma; 2009; 18(8):589-94. PubMed ID: 19826387
[TBL] [Abstract][Full Text] [Related]
6. The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma.
Gupta V; Jha R; Rao A; Kong G; Sihota R
Eur J Ophthalmol; 2009; 19(3):435-41. PubMed ID: 19396791
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.
dell'Omo R; Kulkarni A; Franks WA
Acta Ophthalmol; 2008 Sep; 86(6):698-700. PubMed ID: 18081905
[No Abstract] [Full Text] [Related]
8. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.
Batioğlu F; Astam N; Ozmert E
Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852
[TBL] [Abstract][Full Text] [Related]
9. Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumab injection.
Ishibashi S; Tawara A; Sohma R; Kubota T; Toh N
Arch Ophthalmol; 2010 Dec; 128(12):1539-45. PubMed ID: 21149776
[TBL] [Abstract][Full Text] [Related]
10. Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients.
Duch S; Buchacra O; Milla E; Andreu D; Tellez J
J Glaucoma; 2009 Feb; 18(2):140-3. PubMed ID: 19225351
[TBL] [Abstract][Full Text] [Related]
11. The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma.
Georgalas I; Koutsandrea C; Papaconstantinou D; Petrou P; Ladas I
Eur J Ophthalmol; 2010; 20(1):251; author reply 252. PubMed ID: 20047184
[No Abstract] [Full Text] [Related]
12. Simultaneous intravitreal and intracameral injection of bevacizumab (Avastin) in neovascular glaucoma.
Yuzbasioglu E; Artunay O; Rasier R; Sengul A; Bahcecioglu H
J Ocul Pharmacol Ther; 2009 Jun; 25(3):259-64. PubMed ID: 19348598
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab.
Lupinacci AP; Calzada JI; Rafieetery M; Charles S; Netland PA
Adv Ther; 2009 Feb; 26(2):208-16. PubMed ID: 19234680
[TBL] [Abstract][Full Text] [Related]
14. Intracameral bevacizumab in the treatment of neovascular glaucoma and exudative retinal detachment after brachytherapy in choroidal melanoma.
Vásquez LM; Somani S; Altomare F; Simpson ER
Can J Ophthalmol; 2009 Feb; 44(1):106-7. PubMed ID: 19169330
[No Abstract] [Full Text] [Related]
15. Bevacizumab (Avastin) for the treatment of neovascular glaucoma.
Chilov MN; Grigg JR; Playfair TJ
Clin Exp Ophthalmol; 2007 Jul; 35(5):494-6. PubMed ID: 17651259
[TBL] [Abstract][Full Text] [Related]
16. Concentration of vascular endothelial growth factor after intracameral bevacizumab injection in eyes with neovascular glaucoma.
Lim TH; Bae SH; Cho YJ; Lee JH; Kim HK; Sohn YH
Korean J Ophthalmol; 2009 Sep; 23(3):188-92. PubMed ID: 19794946
[TBL] [Abstract][Full Text] [Related]
17. Intracameral injection of bevacizumab for the treatment of neovascular glaucoma.
Wolf A; von Jagow B; Ulbig M; Haritoglou C
Ophthalmologica; 2011; 226(2):51-6. PubMed ID: 21546781
[TBL] [Abstract][Full Text] [Related]
18. Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma.
Silva Paula J; Jorge R; Alves Costa R; Rodrigues Mde L; Scott IU
Acta Ophthalmol Scand; 2006 Aug; 84(4):556-7. PubMed ID: 16879583
[No Abstract] [Full Text] [Related]
19. Regression of neovascular iris vessels by intravitreal injection of bevacizumab.
Mason JO; Albert MA; Mays A; Vail R
Retina; 2006 Sep; 26(7):839-41. PubMed ID: 16963866
[No Abstract] [Full Text] [Related]
20. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
Kotecha A; Spratt A; Ogunbowale L; dell'Omo R; Kulkarni A; Bunce C; Franks WA
Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
